Daniele Cretella

Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells

Mara Bonelli, Graziana Digiacomo, Claudia Fumarola et al. · Neoplasia · 2017 · 102 citations · Full text

The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

Daniele Cretella, Andrea Ravelli, Claudia Fumarola et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 99 citations · Full text

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

Silvia La Monica, Daniele Cretella, Mara Bonelli et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 89 citations · Full text

Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells

Daniele Cretella, Claudia Fumarola, Mara Bonelli et al. · Scientific Reports · 2019 · 86 citations · Full text

Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR- Activating Mutation

Silvia La Monica, Denise Madeddu, Marcello Tiseo et al. · Journal of Thoracic Oncology · 2016 · 78 citations

Signal Transduction, Signaling Pathway, Receptor Tyrosine Kinase +7